Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Braxia Scientific Corp C.BRAX

Alternate Symbol(s):  BRAXF

Braxia Scientific Corp. is a Canada-based medical research and telemedicine company with a clinic that provide ketamine treatments for persons with depression and related disorders. Through its medical solutions, it intends to reduce the illness burden of brain-based disorders, such as major depressive disorder, among others. The Company is primarily focused on owning and operating... see more

CSE:BRAX - Post Discussion

Braxia Scientific Corp > NEW ANNOUNCEMENT!
View:
Post by Bronson on Nov 24, 2020 4:13pm

NEW ANNOUNCEMENT!

VANCOUVER, BCNov. 24, 2020 /CNW/ - Champignon Brands Inc. (the "Company"), (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), announced today that the Company's management and governance is undergoing comprehensive change at the top that will extend to the Company's practices.

In today's update the Company announces a series of moves now underway as a basis for emphasized priorities on transparency, full and accurate public reporting plus operational readiness to meet the accelerating, pandemic-drive demand for its clinical services.

In this light, the Company reminds investors it is now led by a new Board Chair and CEO and new Vice-Chair, both announced previously (see news release dated October 5, 2020). Other changes underway include the following:

  • The Company is now actively recruiting a new Chief Financial Officer, Chief General Counsel, and Senior Vice President – Investor and Public Communications.
  • The Company intends to expand its board with additional outside directors to be drawn from business and science.
  • The Company has accepted the resignation of Gareth Birdsall, director, effective November 23, 2020.
  • The Company has re-designed its website to facilitate proper access to current information by investors and the wider public.

The current Board of Directors consists of Dr. Roger McIntyre, Chair and CEO; Bill Wilkerson, Vice-Chair; Matt Fish, President and Secretary; and Jerry Habuda

 
Comment by newcoin on Nov 24, 2020 4:47pm
Champignon Brands Inc. (https://champignonbrands.com) is a research-driven Company specializing in breakthrough ketamine treatment for depression, and other mental health conditions and its suicidal implications as well as delivery platforms for other health products. The Company works closely with subsidiaries that include AltMed Capital Corp. (“AltMed”), Novo Formulations Ltd., Artisan Growers ...more  
Comment by Greensavage on Nov 24, 2020 4:53pm
so imo, they're cleaning house? Any thoughts on this...
Comment by TruthBeTold7 on Nov 24, 2020 4:55pm
This post has been removed in accordance with Community Policy
Comment by cautiousguy on Nov 24, 2020 5:03pm
Hey NWEETCONE bite me.  For the last six months I was "accused" of bashing,  Now Champignon brands appear to have finally done almost everything I was advocating.  I'm not saying I'm responsible.  I am saying now NEWTCONE is cheering the news.  Cheering the news after Jeering me for saying the same things the release has now promised.
Comment by GREENBOY on Nov 24, 2020 5:14pm
This post has been removed in accordance with Community Policy
Comment by newcoin on Nov 24, 2020 5:07pm
They're doing what it takes to get trading again and stay trading. Probably a lot more too but we'll have to wait on that. In any event they're alive and well and working toward getting out from under the CTO. Excellent!!
Comment by disosa on Nov 24, 2020 5:30pm
am i missing something? they don't have a CFO ? how will they resolve those filing problems in next weeks? it take weeks to find a new CFO ,and then again weeks before he is updated. so in 2020 no new news on the CTO i guess..hopefully Q1 2021 but i wouldn't bet on it...maybe q2 2021 we are back trading...so another 3-6 months of patience.. good news is that by then we should have a ...more  
Comment by Greensavage on Nov 24, 2020 5:36pm
makes a decent point. Will they now blame improper filing on not having a CFO.
Comment by GREENBOY on Nov 24, 2020 6:31pm
This post has been removed in accordance with Community Policy
Comment by Bofovom1 on Nov 24, 2020 6:42pm
It's been several times now that SHRM releases a PR and someone posts it here, and then Newcoin posts it again a little later. As if he's trying to be the one that brought us the news, yet he's the one that on many occasions criticized folks for posting non relevant posts. Someone just posted it!!! You don't need to post it again moron
Comment by GREENBOY on Nov 24, 2020 8:00pm
This post has been removed in accordance with Community Policy
Comment by cautiousguy on Nov 24, 2020 7:18pm
The acronym CFO would stand for something quite different
Comment by GREENBOY on Nov 24, 2020 8:02pm
This post has been removed in accordance with Community Policy
Comment by cautiousguy on Nov 24, 2020 8:51pm
While I could be more colourful, I will leave it at completely foolish oaf.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities